Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

More than half of neurology fellows experience burnout

A recent study, published in Neurology, found more than half of neurology fellows experience at least one symptom of burnout.

WebMD close to sale to private equity firm for $2.8B

KKR & Co. is nearing an all-cash deal to purchase WebMD Health Corp—including its eponymous flagship website for health professionals and curious consumers—for a reported $2.8 billion.

Thumbnail

Q&A: Avalere finds most ACOs would benefit from taking on downside risk with APM bonus

If the 5 percent bonus payment in the Advanced Alternative Payment Model (APMs) track was available in 2015, accountable care organizations (ACOs) would’ve earned additional net payments of $886 million if they had assumed downside risk under the Medicare Shared Savings Program (MSSP).

Senate plans Tuesday healthcare vote—but doesn’t know what bill will be considered

Senate Republican leaders are pushing for a July 25 vote on some form of legislation to repeal the Affordable Care Act, but haven’t decided on what will be in the bill.

Virtual reality system recreates real-life tasks to improve patient development

Saebo, a producer of medical devices focused on engagement and development, has received clearance from the U.S. Food and Drug Administration (FDA) for its SaeboVR software system. The system is a rehabilitation program designed to use virtual reality to help patients engage in physical and cognitive activities.

M&A activity increased among larger systems in 2nd quarter

Thirty-one partnership transactions among hospitals and health systems were announced in the second quarter of 2017, and 58 have been announced so far this year, according to an analysis on merger and acquisition (M&A) activity by Skokie, Ill.-based consulting firm Kaufman Hall.

Thumbnail

Physician compensation up nearly 3%; productivity, collections flat as costs rise

Most doctors saw a similar increase in compensation last year as they had in 2015, with an average raise of 2.9 percent across all specialties reported in the American Medical Group Association’s (AMGA) annual medical group compensation and productivity survey. Productivity, however, remained flat, and the move to value-based incentives in compensation continues to be slower than anticipated.

Thumbnail

CBO scores 2 Republican healthcare bills

The Congressional Budget Office (CBO) has released reports on two Republican proposals regarding the Affordable Care Act: One which would repeal much of the law while delaying some of those effects for two years and another which replaces it with the Senate's Better Care Reconciliation Act (BCRA).

Displaying 4417 - 4424 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup